Geode Capital Management’s Sonnet BioTherapeutics SONN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9K | Buy |
24,892
+87
| +0.4% | +$108 | ﹤0.01% | 4298 |
|
|
2025
Q1 | $33.2K | Buy |
+24,805
| New | +$33.2K | ﹤0.01% | 4266 |
|
|
2024
Q3 | – | Sell |
-16,704
| Closed | -$15.7K | – | 4578 |
|
|
2024
Q2 | $15.7K | Buy |
+16,704
| New | +$15.7K | ﹤0.01% | 4492 |
|
|
2023
Q3 | – | Sell |
-169,392
| Closed | -$83K | – | 4779 |
|
|
2023
Q2 | $83K | Buy |
169,392
+140,476
| +486% | +$68.8K | ﹤0.01% | 4390 |
|
|
2023
Q1 | $10.4K | Sell |
28,916
-551
| -2% | -$198 | ﹤0.01% | 4763 |
|
|
2022
Q4 | $33K | Sell |
29,467
-22,503
| -43% | -$25.2K | ﹤0.01% | 4695 |
|
|
2022
Q3 | $76K | Sell |
51,970
-675,671
| -93% | -$988K | ﹤0.01% | 4672 |
|
|
2022
Q2 | $203K | Buy |
727,641
+62,485
| +9% | +$17.4K | ﹤0.01% | 4255 |
|
|
2022
Q1 | $250K | Sell |
665,156
-461,353
| -41% | -$173K | ﹤0.01% | 4270 |
|
|
2021
Q4 | $465K | Buy |
1,126,509
+629,752
| +127% | +$260K | ﹤0.01% | 4092 |
|
|
2021
Q3 | $301K | Buy |
496,757
+481,060
| +3,065% | +$291K | ﹤0.01% | 4267 |
|
|
2021
Q2 | $24K | Hold |
15,697
| – | – | ﹤0.01% | 4706 |
|
|
2021
Q1 | $35K | Hold |
15,697
| – | – | ﹤0.01% | 4426 |
|
|
2020
Q4 | $35K | Buy |
+15,697
| New | +$35K | ﹤0.01% | 4210 |
|
|
2017
Q2 | – | Sell |
-92,136
| Closed | -$33K | – | 4104 |
|
|
2017
Q1 | $33K | Hold |
92,136
| – | – | ﹤0.01% | 4004 |
|
|
2016
Q4 | $37K | Hold |
92,136
| – | – | ﹤0.01% | 3951 |
|
|
2016
Q3 | $50K | Hold |
92,136
| – | – | ﹤0.01% | 3914 |
|
|
2016
Q2 | $39K | Hold |
92,136
| – | – | ﹤0.01% | 3962 |
|
|
2016
Q1 | $74 | Hold |
92,136
| – | – | ﹤0.01% | 3900 |
|
|
2015
Q4 | $92K | Hold |
92,136
| – | – | ﹤0.01% | 3899 |
|
|
2015
Q3 | $101K | Buy |
92,136
+46,068
| +100% | +$50.5K | ﹤0.01% | 3892 |
|
|
2015
Q2 | $113K | Buy |
+46,068
| New | +$113K | ﹤0.01% | 3747 |
|